← Leaderboards
Xiaofei Jia
University Of Massachusetts Dartmouth
$2,523,385
Attributed
$4,462,508
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,462,508 · 4
By mechanism
R01$3,497,702 · 2
R56$538,606 · 1
R21$426,200 · 1
Top collaborators
- John Guatelli7 shared
- Rudi Fasan5 shared
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsRecruitNef ProteinInfectionMediatingLaboratoriesCellsClathrin AdaptorsHiv-1ImmuneDrug DiscoveryIn VitroAnti-Retroviral AgentsDown-RegulationAffinityCd4 Positive T LymphocytesCell SurfaceClathrinEnhancer-Binding Protein Ap-2BindingComplexBiochemicalDesignResolution
Grant awards (11)
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication$647,861
R01 · FY2025 · AI · contact PI
Elucidating the Structural Bases of HIV-1-Induced CD4 Degradation$467,559
R01 · FY2025 · AI · contact PI
Elucidating the Structural Bases of HIV-1-Induced CD4 Degradation$448,412
R01 · FY2025 · AI · contact PI
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication$655,537
R01 · FY2024 · AI · contact PI
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication$45,270
R01 · FY2024 · AI · contact PI
Elucidating the Structural Bases of HIV-1-Induced CD4 Degradation$1
R01 · FY2024 · AI · contact PI
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication$701,761
R01 · FY2023 · AI · contact PI
Elucidating the Structural Bases of HIV-1-Induced CD4 Degradation$531,301
R01 · FY2023 · AI · contact PI
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication$538,606
R56 · FY2022 · AI · contact PI
High-Throughput Screening for Multifunctional Nef Inhibitors: Targeting HIV through Revitalizing Immune Defense Mechanisms$225,600
R21 · FY2021 · AI · contact PI
High-Throughput Screening for Multifunctional Nef Inhibitors: Targeting HIV through Revitalizing Immune Defense Mechanisms$200,600
R21 · FY2020 · AI · contact PI